Terazosin is an alpha-1 adrenergic receptor blocker commonly prescribed to treat hypertension and benign prostatic hyperplasia (BPH) by relaxing blood vessels and prostate muscles to improve blood flow and urinary function. It does not significantly affect heart rate and is generally well-tolerated. Maintaining the pharmaceutical purity of Terazosin is essential to ensure its safety, therapeutic effectiveness, and compliance with regulatory standards. Impurity profiling is crucial to detect and control unwanted by-products that may form during manufacturing, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 1 of 1 products
Catalogue No : TERA-OCL-001
CAS No : 23680-84-4
In Stock
Synonyms
Terazosin EP Impurity A 4-Amino-2-chloro-6,7-dimethoxyquinazoline
Terazosin EP Impurity A 4-Amino-2-chloro-6,7-dimethoxyquinazoline